Julie R Park Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• A Phase 3 randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children’s Oncology Group (COG) study — Plenary Session 4
• Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01: A phase 1 study of autologous T-cells lentivirally transduced to express CD171-specific Chimeric Antigen Receptors (CAR) for recurrent/refractory high-risk neuroblastoma (HR-NB) — Parallel 12 Immunotherapy and Early Phase Trials